Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1406 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Laureate Pharma establishes Regulatory Affairs group

Burford will establish and expand regulatory affairs services to support Laureate clients’ clinical programs. The new regulatory affairs service offerings will include, expert advice regarding preclinical and clinical

SCOLR Pharma Q3 revenues drop 53%

Based in Bothell, Washington, SCOLR Pharma is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter and

Antares Pharma Q3 revenue climbs 89%

Antares Pharma has posted a net loss of $1.63m for the third quarter 2010, or $0.02 loss per diluted share, compared to net loss of $2.82m, or $0.04

Theratechnologies Egrifta gets FDA nod

Theratechnologies claimed that Egrifta, the first FDA-approved treatment for lipodystrophy, is a growth hormone releasing factor (GRF)drug that is administered in a once-daily injection. Egrifta was evaluated in